UQ Centre for Clinical Research,
Mater Research and Mater Research Institute
Jodi Saunus has not added Biography.
If you are Jodi Saunus and would like to personalize this page please email our Author Liaison for assistance.
Regulation of BRCA1 messenger RNA stability in human epithelial cell lines and during cell cycle progression.
FEBS letters Jul, 2007 | Pubmed ID: 17612526
Cellular and molecular mechanisms of resistance to oral Candida albicans infections.
Frontiers in bioscience : a journal and virtual library May, 2008 | Pubmed ID: 18508591
Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
Cancer research Nov, 2008 | Pubmed ID: 19010922
Molecular aspects of breast cancer metastasis to the brain.
Genetics research international , 2011 | Pubmed ID: 22567347
In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.
PloS one , 2013 | Pubmed ID: 23750209
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Oncotarget Feb, 2015 | Pubmed ID: 25668816
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.
Nature communications Mar, 2015 | Pubmed ID: 25813983
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
PloS one , 2015 | Pubmed ID: 25969993
Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
International journal of cancer Apr, 2016 | Pubmed ID: 26619948
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Scientific reports 05, 2016 | Pubmed ID: 27148852
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Human molecular genetics 08, 2016 | Pubmed ID: 27378691
SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer.
Oncotarget 11, 2016 | Pubmed ID: 27637080
'Omics Approaches in Breast Cancer Research and Clinical Practice.
Advances in anatomic pathology Nov, 2016 | Pubmed ID: 27740960
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.
International journal of molecular sciences Jan, 2017 | Pubmed ID: 28098771
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast cancer research and treatment 01, 2018 | Pubmed ID: 28889351
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
The Journal of pathology 04, 2018 | Pubmed ID: 29344954
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
Histopathology Jul, 2018 | Pubmed ID: 29465777
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient.
Breast cancer research and treatment Jul, 2018 | Pubmed ID: 29468485
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.
EMBO molecular medicine 09, 2018 | Pubmed ID: 30108112
Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
The journal of pathology. Clinical research 01, 2019 | Pubmed ID: 30246500
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
The Journal of pathology 02, 2019 | Pubmed ID: 30350370
Recent advances in breast cancer research impacting clinical diagnostic practice.
The Journal of pathology 04, 2019 | Pubmed ID: 30426489
Calcium signalling and breast cancer.
Seminars in cell & developmental biology 10, 2019 | Pubmed ID: 30439562
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.
JCI insight 02, 2019 | Pubmed ID: 30830863
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases.
International journal of molecular sciences Mar, 2019 | Pubmed ID: 30875730
Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
Oncogene Jun, 2019 | Pubmed ID: 31068665
Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.
International journal of molecular sciences May, 2019 | Pubmed ID: 31121957
LobSig is a multigene predictor of outcome in invasive lobular carcinoma.
NPJ breast cancer , 2019 | Pubmed ID: 31263747
Breast Cancer Heterogeneity in Primary and Metastatic Disease.
Advances in experimental medicine and biology , 2019 | Pubmed ID: 31456181
Non-coding RNAs underlie genetic predisposition to breast cancer.
Genome biology 01, 2020 | Pubmed ID: 31910864
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer.
Life science alliance 07, 2020 | Pubmed ID: 32423906
Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.
JAMA network open 07, 2020 | Pubmed ID: 32633764
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.
British journal of cancer 11, 2020 | Pubmed ID: 32939056
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S) in human breast cancers and matching brain metastases.
Therapeutic advances in medical oncology , 2020 | Pubmed ID: 33014146
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.
British journal of cancer 01, 2021 | Pubmed ID: 33024263
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.
Biology 05, 2021 | Pubmed ID: 34064871
Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts.
Biomedicines Jun, 2021 | Pubmed ID: 34208665
Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases.
Cancers Jan, 2022 | Pubmed ID: 35158800
Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.
Diseases (Basel, Switzerland) Feb, 2022 | Pubmed ID: 35225863
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.
BMC cancer Mar, 2022 | Pubmed ID: 35346112
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.
NPJ breast cancer May, 2022 | Pubmed ID: 35501337
Malcolm Lim1,
Nicholas Fletcher2,
Amy McCart Reed1,
Melanie Flint3,
Kristofer Thurecht2,
Jodi Saunus*,1,4,
Sunil R. Lakhani*,1,5
1UQ Centre for Clinical Research, The University of Queensland,
2Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology and ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland,
3School of Biomedical Sciences, The University of Queensland,
4Mater Research and Mater Research Institute, The University of Queensland,
5Pathology Queensland, Royal Brisbane Women's Hospital